CareDx, Inc: DCF model
A discounted-cash-flow model filled in from CareDx, Inc's filings as reported. Change any assumption; the values follow at once.
A tool for your own analysis, not investment advice. It does arithmetic on the figures the company filed and on assumptions you choose; it does not forecast, and the result is only as good as those assumptions. Every formula is on the methodology page.
Market price USD 64.00 on Oct 19, 2026: Closing price the SEC publishes with its fails-to-deliver data (CDNA).
Assumptions: Base case
Change any figure; the values follow at once.
Revenue and margins
From the filings10-K filed Feb 25, 2026
The years between change on a straight line.
From the filingsThe first year starts at Revenue growth a year from FY2022 to FY2025 (3 years): 5.68% a year; the years after are your assumption.
The years between change on a straight line.
From the filingsAverage operating margin, FY2023–FY2025: -22.81%; the years ahead are your assumption.
Tax and reinvestment
Your assumptionThe effective rate cannot be worked out (losses or no tax line): 25% to start with.
From the filingsAverage share of revenue, FY2023–FY2025
Your assumptionNot on file: set equal to depreciation and amortisation.
From the filingsAverage operating working capital (current assets less cash and short-term investments, less current liabilities other than debt) as a share of revenue, FY2023–FY2025
Discount rate
Your assumption1.0 to start with
Your assumption5% to start with
Your assumptionNot on file: the risk-free rate plus 1.5 points.
From the filingsDebt over debt plus market value on Oct 19, 2026
After the last year
Your assumption2.5% to start with.
From value to shares (every case)
Balance sheet of Q3FY2026, Sep 30, 2026 · 10-Q filed Oct 29, 2026
From the filings
From the filings
From the filings
From the filings
Your assumption
From the filingsdiluted, weighted average, Q3FY2026 · 10-Q filed Oct 29, 2026
The three cases
Base case: value per share
Discount rate 10.15%; long-run growth 2.50%. Values as at the end of FY2025.
| Present value of the 5 projected years | −USD 372 M |
|---|---|
| Present value after the last year | −USD 874 M |
| Enterprise value (the whole business) | −USD 1.2 B |
| Less debt | USD 0 |
| Plus cash and short-term investments | USD 250 M |
| Equity value (the shareholders') | −USD 995 M |
| Divided by shares (millions) | 55 |
| Value per share | USD -18.10 |
Value per share
USD -18.10
Below zero: with these figures the debt is worth more than the business.
Price USD 64.00 on Oct 19, 2026
Base case: year by year
Millions of USD. The FY2025 column is as reported; the years after are projected. Tax, capital spending and working capital are signed as they add to (+) or take from (−) free cash flow.
| USD millions | FY2025reported | FY2026projected | FY2027projected | FY2028projected | FY2029projected | FY2030projected |
|---|---|---|---|---|---|---|
| Revenue | 380 | 401 | 421 | 438 | 453 | 464 |
| Growth | 13.8% | 5.7% | 4.9% | 4.1% | 3.3% | 2.5% |
| Operating income (EBIT) | −31 | −92 | −96 | −100 | −103 | −106 |
| Operating margin | -8.1% | -22.8% | -22.8% | -22.8% | -22.8% | -22.8% |
| Tax on operating income | −0 | −0 | −0 | −0 | −0 | |
| Depreciation and amortisation | 15 | 18 | 19 | 20 | 20 | 21 |
| Capital spending | — | −18 | −19 | −20 | −20 | −21 |
| Change in working capital | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Free cash flow to the firm | −4 | −91 | −96 | −100 | −103 | −106 |
| Discount factor | 0.9079 | 0.8242 | 0.7482 | 0.6793 | 0.6167 | |
| Present value | −83 | −79 | −75 | −70 | −65 |
Base case: sensitivity
How the value per share moves when one pair of figures changes and the rest stay as they are.
Discount rate and long-run growth
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Discount rate ↓ · Long-run growth → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 8.15% | -22.42 | -24.14 | -26.17 | -28.58 | -31.52 |
| 9.15% | -18.86 | -20.1 | -21.53 | -23.19 | -25.14 |
| 10.15% | -16.13 | -17.06 | -18.1 | -19.3 | -20.67 |
| 11.15% | -13.96 | -14.68 | -15.47 | -16.37 | -17.38 |
| 12.15% | -12.2 | -12.77 | -13.39 | -14.08 | -14.84 |
Revenue growth and operating margin
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Growth, every year ↓ · Margin, every year → | −4 pt | −2 pt | ±0 pt | +2 pt | +4 pt |
|---|---|---|---|---|---|
| −4 pt | -17.95 | -16.27 | -14.59 | -12.91 | -11.23 |
| −2 pt | -19.94 | -18.11 | -16.28 | -14.46 | -12.63 |
| ±0 pt | -22.08 | -20.09 | -18.1 | -16.12 | -14.13 |
| +2 pt | -24.38 | -22.22 | -20.06 | -17.9 | -15.74 |
| +4 pt | -26.85 | -24.5 | -22.16 | -19.81 | -17.46 |
Where the figures come from
The statements as reported, in millions of USD; hover a figure for its filing.
| USD millions | FY2025to Dec 31, 2025 | FY2024to Dec 31, 2024 | FY2023to Dec 31, 2023 | FY2022to Dec 31, 2022 | FY2021to Dec 31, 2021 | FY2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 380 | 334 | 280 | 322 | 296 | 192 |
| Growth | 13.8% | 19.1% | -12.9% | 8.6% | 54.2% | — |
| Operating income | −31 | 41 | −203 | −77 | −30 | −23 |
| Operating margin | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% |
| Effective tax rate | — | 0.6% | — | — | — | — |
| D&A, % of revenue | 4.0% | 4.3% | 5.1% | 3.6% | 3.0% | 3.6% |
| Capital spending, % of revenue | — | — | — | — | — | — |
| Working capital, % of revenue | -2.6% | 0.5% | 0.1% | 5.8% | 2.6% | -10.8% |
| Free cash flow to the firm | −4 | 53 | −170 | −77 | −49 | — |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
- No debt is tagged on the balance sheet of Q3FY2026: debt starts at zero.
- From the filings: revenue, margins, tax rate, depreciation, capital spending and working capital (fiscal years above), debt, cash, leases and minority interests (balance sheet of Q3FY2026), and the share count (Q3FY2026).
- Market data: US Treasury daily par yield curve, 10-year (Nov 13, 2026); Market price USD 64.00 on Oct 19, 2026: Closing price the SEC publishes with its fails-to-deliver data (CDNA).
- Your assumptions: the growth path and margins ahead, beta, the equity risk premium, long-run growth or the exit multiple, and the weights of the cases. How each figure is worked out: methodology.